Literature DB >> 12972426

Temporal and spatial modulation of Rho GTPases during in vitro formation of capillary vascular network. Adherens junctions and myosin light chain as targets of Rac1 and RhoA.

Ilaria Cascone1, Enrico Giraudo, Francesca Caccavari, Lucia Napione, Elisa Bertotti, John G Collard, Guido Serini, Federico Bussolino.   

Abstract

Endothelial cells (ECs) self-organize into capillary networks when plated on extracellular matrix. In this process, Rho GTPases-mediated cytoskeletal dynamics control cell movement and organization of cell-to-matrix and cell-to-cell contacts. Time course analysis of RhoA and Rac1 activation matches specific morphological aspects of nascent pattern. RhoA-GTP increases early during EC adhesion and accumulates at sites of membrane ruffling. Rac1 is activated later and localizes in lamellipodia and at cell-to-cell contacts of organized cell chains. When ECs stretch and remodel to form capillary structures, RhoA-GTP increases again and associates with stress fibers running along the major cell axis. N17Rac1 and N19RhoA mutants impair pattern formation. Cell-to-cell contacts and myosin light chains (MLC) are targets of Rac1 and RhoA, respectively. N17Rac1 reduces the shift of beta-catenin and vascular endothelial cadherin to Triton X-100-insoluble fraction and impairs beta-catenin distribution at adherens junctions, suggesting that Rac1 controls the dynamics of cadherin-catenin complex with F-actin. During the remodeling phase of network formation, ECs show an intense staining for phosphorylated MLC along the plasma membrane; in contrast, MLC is less phosphorylated and widely diffused in N19RhoA ECs. Both N17Rac1 and N19RhoA have been used to investigate the role of wild type molecules in the main steps characterizing in vitro angiogenesis: (i) cell adhesion to the substrate, (ii) cell movement, and (iii) mechanical remodeling of matrix. N17Rac1 has a striking inhibitory effect on haptotaxis, whereas N19RhoA slightly inhibits EC adhesion and motility but more markedly Matrigel contraction. We conclude that different Rho GTPases control distinct morphogenetic aspects of vascular morphogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12972426     DOI: 10.1074/jbc.M307234200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Rho activity critically and selectively regulates endothelial cell organization during angiogenesis.

Authors:  Mien V Hoang; Mary C Whelan; Donald R Senger
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

2.  Active Rac1 improves pathologic VEGF neovessel architecture and reduces vascular leak: mechanistic similarities with angiopoietin-1.

Authors:  Mien V Hoang; Janice A Nagy; Donald R Senger
Journal:  Blood       Date:  2010-10-28       Impact factor: 22.113

3.  FAK potentiates Rac1 activation and localization to matrix adhesion sites: a role for betaPIX.

Authors:  Fumin Chang; Christopher A Lemmon; Dongeun Park; Lewis H Romer
Journal:  Mol Biol Cell       Date:  2006-11-08       Impact factor: 4.138

4.  Regulation of lymphatic-blood vessel separation by endothelial Rac1.

Authors:  Gabriela D'Amico; Dylan T Jones; Emma Nye; Karen Sapienza; Antoine R Ramjuan; Louise E Reynolds; Stephen D Robinson; Vassiliki Kostourou; Dolores Martinez; Deborah Aubyn; Richard Grose; Gareth J Thomas; Bradley Spencer-Dene; Daniel Zicha; Derek Davies; Victor Tybulewicz; Kairbaan M Hodivala-Dilke
Journal:  Development       Date:  2009-12       Impact factor: 6.868

5.  Endothelial RhoGEFs: A systematic analysis of their expression profiles in VEGF-stimulated and tumor endothelial cells.

Authors:  Ricardo Hernández-García; M Luisa Iruela-Arispe; Guadalupe Reyes-Cruz; José Vázquez-Prado
Journal:  Vascul Pharmacol       Date:  2015-10-17       Impact factor: 5.773

6.  Platelet-activating factor increases VE-cadherin tyrosine phosphorylation in mouse endothelial cells and its association with the PtdIns3'-kinase.

Authors:  Hélène Hudry-Clergeon; Dominique Stengel; Ewa Ninio; Isabelle Vilgrain
Journal:  FASEB J       Date:  2005-04       Impact factor: 5.191

7.  Characterization of FGD5 Expression in Primary Breast Cancers and Lymph Node Metastases.

Authors:  Marit Valla; Patricia G Mjønes; Monica J Engstrøm; Borgny Ytterhus; Diana L Bordin; Barbara van Loon; Lars A Akslen; Lars J Vatten; Signe Opdahl; Anna M Bofin
Journal:  J Histochem Cytochem       Date:  2018-07-27       Impact factor: 2.479

8.  Endothelial-Rac1 is not required for tumor angiogenesis unless alphavbeta3-integrin is absent.

Authors:  Gabriela D'Amico; Stephen D Robinson; Mitchel Germain; Louise E Reynolds; Gareth J Thomas; George Elia; Garry Saunders; Marcus Fruttiger; Victor Tybulewicz; Georgia Mavria; Kairbaan M Hodivala-Dilke
Journal:  PLoS One       Date:  2010-03-22       Impact factor: 3.240

9.  Latrunculin A and its C-17-O-carbamates inhibit prostate tumor cell invasion and HIF-1 activation in breast tumor cells.

Authors:  Khalid A El Sayed; Mohammad A Khanfar; Hassan M Shallal; A Muralidharan; Bhushan Awate; Diaa T A Youssef; Yang Liu; Yu-Dong Zhou; Dale G Nagle; Girish Shah
Journal:  J Nat Prod       Date:  2008-02-26       Impact factor: 4.050

10.  Antiangiogenic properties of fasudil, a potent Rho-Kinase inhibitor.

Authors:  Yasuaki Hata; Muneki Miura; Shintaro Nakao; Shuhei Kawahara; Takeshi Kita; Tatsuro Ishibashi
Journal:  Jpn J Ophthalmol       Date:  2008-03-28       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.